Pretreatment to Enhance Protoporphyrin IX Accumulation in Photodynamic Therapy
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The response rates of photodynamic therapy (PDT) vary widely. Limited uptake of topically applied 5-aminolaevulinic acid (ALA), or its methyl ester (MAL), and suboptimal production of protoporphyrin IX (PpIX) may account for these differences. Recently, we demonstrated that hyperkeratosis is an important negative factor in ALA uptake. This review has its focus on pretreatment of the skin in order to improve the clinical outcome of ALA/MAL PDT. Pretreatment of hyperkeratosis can be achieved with keratolytics, curettage/debulking, tape stripping, microdermabrasion or laser ablation. Penetration enhancers may alter the composition or organization of the intercellular lipids of the stratum corneum. Several studies have been performed on the use of dimethyl sulfoxide, azone, glycolic acid, oleic acid and iontophoresis to increase the penetration of ALA. As PpIX production is also dominated by temperature-dependent processes, elevating skin temperature during ALA application may also improve treatment results. Another approach is the use of additives that interact with the heme biosynthetic pathway, e.g. by removing ferrous iron with iron-chelating substances such as: ethylenediaminetetraacetic acid; 3-hydroxypyridin-4-ones; 1,2-diethyl-3-hydroxypyridin-4-one-hydrochloride; and desferrioxamine. In conclusion, simple pretreatments or additions to the regular practice of PDT, aimed to optimize intralesional PpIX content, improve the clinical outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berg, K., Anholt, H., Bech, Ø., & Moan, J. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.423 · Cited by 142
Malik, Z., Kostenich, G., Roitman, L., Ehrenberg, B., & Orenstein, A. (1995) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/1011-1344(95)07117-k · Cited by 138
De Rosa, F. S., Marchetti, J. M., Thomazini, J. A., Tedesco, A. C., & Bentley, M. V. L. B. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00213-8 · Cited by 131
Choudry, K., Brooke, R. C. C., Farrar, W., & Rhodes, L. E. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05351.x · Cited by 65 · cited 1×
“To explore the potential of the iron chelator DFO to enhance PpIX levels in ALA PDT, a series of 6 doses of 2p ALA solution were applied to the healthy skin of each ventral forearm of 10 volunteers via iontophoresis. For 16 h, 1 arm was pretreated with 20p DFO in aqueous cream, while the control arm received aqueous c…”
MethodThe influence of temperature on photodynamic cell killing in vitro with 5-aminolevulinic acid
Juzeniene, A., Juzenas, P., Bronshtein, I., Vorobey, A., & Moan, J. (2006) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/j.jphotobiol.2006.02.009 · Cited by 41
Pye, A., Campbell, S., & Curnow, A. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0358-6 · Cited by 32 · cited 1×
“Enhancement of MAL-induced PpIX accumulation by the iron chelator CP94 was quantified fluorometrically in human cultured cells (including 3 dermatological cell types). Also, an open dose-escalating pilot study was conducted in patients with nodular BCC, to determine the safety of this pharmacological modification. Lar…”
Background
Cited by
Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions
Van Straten, D., Mashayekhi, V., De Bruijn, H., Oliveira, S., & Robinson, D. (2017) · Cancers · doi:10.3390/cancers9020019 · Cited by 1,012
Morton, C. A., Szeimies, R. ‐., Sidoroff, A., & Braathen, L. R. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12031 · Cited by 344
Fractional CO2 laser‐assisted drug delivery
Hædersdal, M., Sakamoto, F. H., Farinelli, W. A., Doukas, A. G., Tam, J., & Anderson, R. R. (2010) · Lasers in Surgery and Medicine · doi:10.1002/lsm.20860 · Cited by 273
Aminolevulinic Acid (ALA) as a Prodrug in Photodynamic Therapy of Cancer
Wachowska, M., Muchowicz, A., Firczuk, M., Gabrysiak, M., Winiarska, M., Wańczyk, M., Bojarczuk, K., & Golab, J. (2011) · Molecules · doi:10.3390/molecules16054140 · Cited by 265
Current evidence and applications of photodynamic therapy in dermatology
Lin, J., & Wan, M. T. (2014) · Clinical, Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s35334 · Cited by 248
Metadata
- Authors
- Gerritsen, M. J. P., Smits, T., Kleinpenning, M. M., van de Kerkhof, P. C. M., & van Erp, P. E. J.
- Venue
- Dermatology
- Publisher
- S. Karger AG
- Published
- 2008-12-11
- Volume
- 218
- Issue
- 3
- Pages
- 193-202
- ISSN
- 1018-8665 (ISSN-L)
- 1421-9832
- OpenAlex
- W2061963298
- Cited by
- 113
- References
- 6
- FWCI
- 7.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pretreatment to Enhance Protoporphyrin IX Accumulation in Photodynamic Therapy. https://app.cochat.ai/papers/10.1159/000183753
- The paper
- Gerritsen, M. J. P., Smits, T., Kleinpenning, M. M., van de Kerkhof, P. C. M., & van Erp, P. E. J. (2009). Pretreatment to Enhance Protoporphyrin IX Accumulation in Photodynamic Therapy. Dermatology. https://doi.org/10.1159/000183753
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.